Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial

✍ Scribed by M. Donadio; E. Manzin; A. Berruti; A. Bottini; G. Gorzegno; S. Danese; E. DeFabiani; M.G. Sarobba; V. Lorusso; F. Castiglione; G. Moro; O. Bertetto; C. Bumma; L. Dogliotti

• Publisher: Springer
• Year: 2001
• Tongue: English
• Weight: 92 KB
• Volume: 47
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s002800000247